Page last updated: 2024-10-28

ifosfamide and Histiocytosis, Langerhans-Cell

ifosfamide has been researched along with Histiocytosis, Langerhans-Cell in 2 studies

Histiocytosis, Langerhans-Cell: A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paris, A1
Dib, M1
Rousselet, MC1
Urban, T1
Tazi, A1
Gagnadoux, F1
Ferringer, T1
Banks, PM1
Metcalf, JS1

Other Studies

2 other studies available for ifosfamide and Histiocytosis, Langerhans-Cell

ArticleYear
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
    Revue des maladies respiratoires, 2011, Volume: 28, Issue:7

    Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmusti

2011
Langerhans cell sarcoma.
    The American Journal of dermatopathology, 2006, Volume: 28, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Disease-Free Survival; Doxoru

2006